Komori
Other Disclosures265AHmcomm Inc.Information and Communications, Services and Others

Notice of Initiation of Research Coverage of Our Shares by Envalis

ENVALITH will begin preparing and distributing equity research reports on Hmcomm Inc. This will provide domestic and international investors with third-party analysis of the company’s business and growth strategy.

Worth reading
45Recurring
Scored from 5 of 6 sections
Direction
Improvement
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Conditional
How definitive the wording is.

Announced details

Research coverage of our shares / equity research reports
Applicable field (uses covered by this announcement)

Equity research, investor communications, IR

Launch date21 July 2026 (the announcement states that coverage will commence; the specific commencement date is unclear from the text)
Relationship between the counterparty and the company
Hmcomm Inc.265A
Relationship with the Company

ENVALITH will commence research coverage of our shares. No capital or personnel relationship is stated.

CounterpartyENVALITH Co., Ltd. (ENVALITH)

An independent equity research platform providing corporate research in Japanese, English and Chinese. It distributes earnings flash reports and corporate analysis reports through financial information networks such as Bloomberg, FactSet, Factiva and AlphaSense, as well as to domestic and international investors.

Location (as indicated in this announcement)

4th Floor, PMO Hamamatsucho III, 2-10-6 Hamamatsucho, Minato-ku, Tokyo (Hmcomm Inc.)

Impact on Business Performance

No information was provided on the impact on business performance.

The company does not address Contract Value / Offering price.

Source (materials cited by the company)

Bloomberg, FactSet, Factiva, AlphaSense and other sources (listed as distribution channels)

Announced details
ItemDetails
Names of Products / Services CoveredResearch coverage of our shares / equity research reports
CounterpartyENVALITH Co., Ltd. (ENVALITH)
Counterparty overviewAn independent equity research platform providing corporate research in Japanese, English and Chinese. It distributes earnings flash reports and corporate analysis reports through financial information networks such as Bloomberg, FactSet, Factiva and AlphaSense, as well as to domestic and international investors.
Relationship with the CompanyENVALITH will commence research coverage of our shares. No capital or personnel relationship is stated.
Launch date21 July 2026 (the announcement states that coverage will commence; the specific commencement date is unclear from the text)
Applicable areaEquity research, investor communications, IR
Location4th Floor, PMO Hamamatsucho III, 2-10-6 Hamamatsucho, Minato-ku, Tokyo (Hmcomm Inc.)
Impact on Business PerformanceNo information was provided on the impact on business performance.
SourceBloomberg, FactSet, Factiva, AlphaSense and other sources (listed as distribution channels)
Items this document does not state (9)
Contract ValueOffering priceContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocation scaleQuantitative EffectsUsage history

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The objectives are to raise awareness among domestic and international investors, enhance the information provided through objective third-party analysis of the company, expand opportunities for dialogue with investors, support appropriate share-price formation and enhancement of corporate value, and promote understanding of the growth strategy.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of Initiation of Research Coverage of Our Shares by Envalis | Hmcomm Inc. (265A) timely disclosure | Komori